Morgan Keegan Lowers PT On Emeritus To $24

August 5, 2011 6:12 AM | 8 seconds read |

Morgan Keegan has lowered the price target on Emeritus Corporation ESC from $29 to $24 and maintains its Outperform rating.

Posted In: Price Target Analyst Ratings Health Care Health Care Facilities Morgan Keegan

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.